Harvard Bioscience, Inc. (HBIO)

0.6125 -0.01 (-1.21%) USD  |  NASDAQ  |  Jan 23, 12:38
More

Harvard Bioscience Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for HBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
Bruker Corp. Upgrade
Azenta, Inc. Upgrade
Precipio, Inc. Upgrade
Bionano Genomics, Inc. Upgrade
Kestra Medical Technologies Ltd. --